{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:06:33Z","timestamp":1789823193271,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.lpm.2011.12.003","type":"journal-article","created":{"date-parts":[[2012,1,30]],"date-time":"2012-01-30T13:45:33Z","timestamp":1327931133000},"page":"304-310","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P1","title":["Traitement de l\u2019insuffisance r\u00e9nale chronique\u00a0: strat\u00e9gie th\u00e9rapeutique"],"prefix":"10.1016","volume":"41","author":[{"given":"Xavier","family":"Belenfant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wided","family":"Tabbi Anani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Roland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Mavel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joelle","family":"Laederich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2011.12.003_bib0005","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimed GFR and albuminuria with all cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"CKD consortium","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2011.12.003_bib0010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ki.2010.531","article-title":"Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high risk population cohorts","volume":"80","author":"Gansevoort","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.lpm.2011.12.003_bib0015","unstructured":"Anaes \/HAS. Recommandations pour la pratique clinique. Moyens th\u00e9rapeutiques pour ralentir la progression de l\u2019insuffisance r\u00e9nale chronique chez l\u2019adulte. 2004. www.has.sante.fr."},{"key":"10.1016\/j.lpm.2011.12.003_bib0020","unstructured":"HAS. Guide d\u2019affection de longue dur\u00e9e. N\u00e9phropathie chronique grave. 2007. www.has.sante.fr."},{"key":"10.1016\/j.lpm.2011.12.003_bib0025","unstructured":"The renal association (UK). Detection, monitoring and care of patients with CKD. 2011. www.renal.org."},{"issue":"Suppl. 1","key":"10.1016\/j.lpm.2011.12.003_bib0030","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines on hypertension and hypertensive agent in chronic kidney disease","volume":"43","author":"Kidney Disease Outcomes Quality Initiative (K\/DIGO)","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.lpm.2011.12.003_bib0035","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartaan in patients with nephropathy due to type 2\u00a0diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2011.12.003_bib0040","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa0708379","article-title":"Aliskiren combined with losartan in type 2\u00a0diabetes and nephropathy","volume":"358","author":"Parving","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2011.12.003_bib0045","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1046\/j.1523-1755.2003.00033.x","article-title":"Retarding progression of chronic renal disease: the neglected issue of residual proteinuria","volume":"63","author":"Ruggenenti","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.lpm.2011.12.003_bib0050","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa0905368","article-title":"Revascularisation versus medical therapy for renal artery stenosis","volume":"361","author":"Investigators","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2011.12.003_bib0055","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.nephro.2007.04.002","article-title":"Th\u00e9rapeutique diur\u00e9tique","volume":"3","author":"Presne","year":"2007","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.lpm.2011.12.003_bib0060","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","article-title":"Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high risk patients","volume":"359","author":"Jamerson","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2011.12.003_bib0065","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(08)61236-2","article-title":"Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (ONTARGET study): a multicentre, randomized, double, controlled trial","volume":"372","author":"Mann","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2011.12.003_bib0070","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1046\/j.1523-1755.2000.00014.x","article-title":"Relationship between nutritional status and the GFR: results from the MDRD study","volume":"57","author":"MDRD group","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.lpm.2011.12.003_bib0075","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1046\/j.1523-1755.2000.00994.x","article-title":"Angiotensin II blockage and low protein diet produce additive therapeutic effects in experimental glomerulonephritis","volume":"57","author":"Peters","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.lpm.2011.12.003_bib0080","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1053\/j.ajkd.2008.08.033","article-title":"Sodium bicarbonate therapy for prevention of contrast induced nephropathy: a systematic review and meta-analysis","volume":"53","author":"Navaneethan","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.lpm.2011.12.003_bib0085","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1093\/ndt\/gfq827","article-title":"Inappropriate drug use and mortality in community-dwelling elderly with impaired kidney function: the three city population-based study","volume":"26","author":"Breton","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.lpm.2011.12.003_bib0090","unstructured":"Afssaps. Traitement de l\u2019an\u00e9mie au cours de l\u2019insuffisance r\u00e9nale chronique de l\u2019adulte. Recommandations. 2005. www.afssaps.fr."},{"key":"10.1016\/j.lpm.2011.12.003_bib0095","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"A trial of darbopoetin alfa in type 2\u00a0diabetes and CKD","volume":"361","author":"Pfeller","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2011.12.003_bib0100","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ki.2010.129","article-title":"Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy","volume":"78","author":"Mahajan","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.lpm.2011.12.003_bib0105","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/j.ajkd.2011.03.020","article-title":"Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies","volume":"58","author":"Piltz","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"Suppl. 113","key":"10.1016\/j.lpm.2011.12.003_bib0110","first-page":"S1","article-title":"K\/DIGO clinical pratice guidelines for diagnostic, evaluation, prevention and treatment of CKD mineral and bone disease","volume":"76","author":"Kidney Disease Outcomes Quality Initiative (K\/DIGO)","year":"2009","journal-title":"Kidney Int"},{"issue":"Suppl. 2","key":"10.1016\/j.lpm.2011.12.003_bib0115","first-page":"S12","article-title":"Clinical practiceguidelines and clinical practice recommandations for diabetes in chronic kideny disease","volume":"49","author":"KDOQI","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.lpm.2011.12.003_bib0120","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/ki.2011.157","article-title":"Smoking is a risk factor in the progression to kidney failure","volume":"80","author":"Hallan","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.lpm.2011.12.003_bib0125","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatine plus ezetimibe in patients with CKD (Study oh heart and renal protection SHARP): a randomized placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2011.12.003_bib0130","unstructured":"Federal Drug Administration (FDA). FDA drug safety communication: new rstrictions, contraindications and dose limitation for simvastatine to reduce the risk of muscle injury. 06\/08\/2011. www.fda.gov\/drugs\/DrugSafety."},{"key":"10.1016\/j.lpm.2011.12.003_bib0135","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/ndt\/gfp640","article-title":"Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts","volume":"25","author":"Afshinnia","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.lpm.2011.12.003_bib0140","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/ndt\/gfm857","article-title":"Primary care-based management of CKD bases on eGFR reporting, improves patient outcomes","volume":"23","author":"Richards","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.lpm.2011.12.003_bib0145","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1053\/j.ajkd.2008.01.024","article-title":"Educational intervention of kidney disease care: a systematic review of randomized trials","volume":"51","author":"Mason","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.lpm.2011.12.003_bib0150","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2215\/CJN.01040905","volume":"1","author":"Chrysostomou","year":"2006","journal-title":"Clin Am Sc Nephrol"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498211006324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498211006324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T14:55:24Z","timestamp":1543244124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498211006324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0755498211006324"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2011.12.003","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}